Literature DB >> 2106831

Tetrahydrohomofolate polyglutamates as inhibitors of thymidylate synthase and glycinamide ribonucleotide formyltransferase in Lactobacillus casei.

J Thorndike1, R L Kisliuk, Y Gaumont, J R Piper, M G Nair.   

Abstract

In order to determine the mechanism for the effects of homofolates on growth of Lactobacillus casei, polyglutamated derivatives of homofolate (HPteGlu), dihydrohomofolate and tetrahydrohomofolate (H4HPteGlu) were synthesized and tested as inhibitors of folate-requiring enzymes. The following L. casei enzymes were examined: thymidylate synthase (TS), glycinamide ribonucleotide formyltransferase (GARFT), aminoimidazolecarboxamide ribonucleotide formyltransferase, serine hydroxymethyltransferase and dihydrofolate reductase. Polyglutamates of (6R,S)-H4HPteGlu are potent inhibitors of TS and GARFT. For example, the IC50 values of (6R,S)-H4HPteGlu6 are 0.7 microM for TS and 0.3 microM for GARFT. By contrast, the value for HPteGlu6 is greater than 10 microM for both TS and GARFT. Inhibition of TS and GARFT by (6R,S)-H4HPteGlu derivatives increases with polyglutamate chain length. For TS, the Glu5 and Glu6 derivatives of (6R,S)-H4HPteGlu are 20 and 30 times more potent than the monoglutamate, respectively. For GARFT, the Glu2-6 derivatives are 2-3 times more potent than Glu1. Inhibition of TS and GARFT by (6R,S)-H4HPteGlu polyglutamates is almost entirely due to the unnatural (6R) diastereomer at C-6. Homofolate derivatives are only weak inhibitors of aminoimidazolecarboxamide ribonucleotide formyltransferase, serine hydroxymethyltransferase, and dihydrofolate reductase. We conclude that both TS and GARFT are potential targets of (6R)-H4HPteGlu polyglutamates.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2106831     DOI: 10.1016/0003-9861(90)90588-p

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  2 in total

1.  The effect of inhibiting glycinamide ribonucleotide formyl transferase on the development of neural tube in mice.

Authors:  Lin Xu; Li Wang; JianHua Wang; ZhiQiang Zhu; Ge Chang; Ying Guo; XinLi Tian; Bo Niu
Journal:  Nutr Metab (Lond)       Date:  2016-08-23       Impact factor: 4.169

2.  Pharmacokinetics, bioavailability, and plasma protein binding study of glytrexate, a novel multitarget antifolate.

Authors:  Jiahong Xiang; Mengqi Wu; Jianchao Wang; Mengmeng Lin; Mengmeng Sun; Xin Li; Ruijuan Xing; Ran Guo; Jianmin Gu; Tao Lyu; Lei Wang; Xiaowei Shi
Journal:  Front Pharmacol       Date:  2022-10-04       Impact factor: 5.988

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.